The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.

Brosch JR, Wang S, Apostolova LG, Agarwal A, Allen JW, Gutmann L, Tobar M, Gonzalez L, Johnson D, Treadway L, Connolly J, Tang A, Lettich E, Davies S, Kuhn N, Hammers DB, Clark D, Farlow M, Willis DR, Fowler N, Wilcock DM.

Open source

DOI: 10.1002/trc2.70291
Published: 2026-07-08
Container: Alzheimers Dement (N Y)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/trc2.70291,
  title = {The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.},
  author = {Brosch JR and  Wang S and  Apostolova LG and  Agarwal A and  Allen JW and  Gutmann L and  Tobar M and  Gonzalez L and  Johnson D and  Treadway L and  Connolly J and  Tang A and  Lettich E and  Davies S and  Kuhn N and  Hammers DB and  Clark D and  Farlow M and  Willis DR and  Fowler N and  Wilcock DM.},
  year = {2026},
  journal = {Alzheimers Dement (N Y)},
  doi = {10.1002/trc2.70291},
  url = {https://doi.org/10.1002/trc2.70291}
}

RIS

TY  - JOUR
TI  - The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.
AU  - Brosch JR
AU  -  Wang S
AU  -  Apostolova LG
AU  -  Agarwal A
AU  -  Allen JW
AU  -  Gutmann L
AU  -  Tobar M
AU  -  Gonzalez L
AU  -  Johnson D
AU  -  Treadway L
AU  -  Connolly J
AU  -  Tang A
AU  -  Lettich E
AU  -  Davies S
AU  -  Kuhn N
AU  -  Hammers DB
AU  -  Clark D
AU  -  Farlow M
AU  -  Willis DR
AU  -  Fowler N
AU  -  Wilcock DM.
PY  - 2026
JO  - Alzheimers Dement (N Y)
DO  - 10.1002/trc2.70291
UR  - https://doi.org/10.1002/trc2.70291
ER  -

APA

JR, B., S, W., LG, A., A, A., JW, A., L, G., M, T., L, G., D, J., L, T., J, C., A, T., E, L., S, D., N, K., DB, H., D, C., M, F., DR, W., N, F., & DM., W. (2026). The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.. Alzheimers Dement (N Y). https://doi.org/10.1002/trc2.70291

Source records

europe-pmc · retrieved 2026-09-25T01:35:06.585Z